Halozyme Therapeutics shares owned by Hsbc Holdings
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hsbc Holdings
from 13F filings
Historical chart of Hsbc Holdings investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Hsbc Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $463k | 6.3k | 73.28 |
| 2025-06-30 | $526k | 10k | 52.02 |
| 2025-03-31 | $297k | 4.7k | 63.76 |
| 2024-12-31 | $460k | 9.6k | 47.81 |
| 2024-09-30 | $362k | 6.3k | 57.24 |
| 2024-06-30 | $567k | 11k | 52.36 |
| 2024-03-31 | $5.0M | 123k | 40.68 |
| 2023-12-31 | $3.7M | 100k | 36.82 |
| 2023-09-30 | $3.0M | 78k | 38.20 |
| 2023-06-30 | $2.1M | 58k | 36.07 |
| 2023-03-31 | $3.8M | 101k | 38.02 |
| 2022-12-31 | $4.8M | 84k | 56.90 |
| 2022-09-30 | $3.3M | 83k | 40.00 |
| 2022-06-30 | $2.2M | 51k | 43.99 |
| 2022-03-31 | $2.3M | 58k | 40.25 |
| 2021-12-31 | $2.6M | 63k | 40.80 |
| 2021-09-30 | $1.8M | 47k | 39.60 |
| 2020-09-30 | $497k | 19k | 26.53 |
| 2020-03-31 | $184k | 10k | 17.76 |
| 2019-12-31 | $234k | 13k | 17.85 |
| 2019-09-30 | $579k | 37k | 15.51 |
| 2019-03-31 | $267k | 17k | 16.10 |
| 2018-12-31 | $157k | 11k | 14.65 |
| 2016-12-31 | $186k | 19k | 9.90 |
| 2012-06-30 | $127k | 13k | 10.00 |